全文获取类型
收费全文 | 1215115篇 |
免费 | 76896篇 |
国内免费 | 1667篇 |
专业分类
耳鼻咽喉 | 17347篇 |
儿科学 | 39713篇 |
妇产科学 | 31957篇 |
基础医学 | 173242篇 |
口腔科学 | 33635篇 |
临床医学 | 105474篇 |
内科学 | 228681篇 |
皮肤病学 | 28479篇 |
神经病学 | 94597篇 |
特种医学 | 49818篇 |
外国民族医学 | 224篇 |
外科学 | 186076篇 |
综合类 | 22688篇 |
现状与发展 | 1篇 |
一般理论 | 301篇 |
预防医学 | 81457篇 |
眼科学 | 28224篇 |
药学 | 96141篇 |
7篇 | |
中国医学 | 3091篇 |
肿瘤学 | 72525篇 |
出版年
2021年 | 8581篇 |
2019年 | 8843篇 |
2018年 | 13735篇 |
2017年 | 10928篇 |
2016年 | 12878篇 |
2015年 | 14341篇 |
2014年 | 18439篇 |
2013年 | 26769篇 |
2012年 | 37685篇 |
2011年 | 39082篇 |
2010年 | 22923篇 |
2009年 | 20963篇 |
2008年 | 36579篇 |
2007年 | 39527篇 |
2006年 | 40114篇 |
2005年 | 38812篇 |
2004年 | 37193篇 |
2003年 | 35793篇 |
2002年 | 34636篇 |
2001年 | 64630篇 |
2000年 | 65967篇 |
1999年 | 54906篇 |
1998年 | 13652篇 |
1997年 | 12000篇 |
1996年 | 11760篇 |
1995年 | 10949篇 |
1994年 | 9914篇 |
1993年 | 9378篇 |
1992年 | 39572篇 |
1991年 | 37948篇 |
1990年 | 37402篇 |
1989年 | 35839篇 |
1988年 | 32231篇 |
1987年 | 31368篇 |
1986年 | 29469篇 |
1985年 | 27638篇 |
1984年 | 20120篇 |
1983年 | 16888篇 |
1982年 | 9363篇 |
1979年 | 18044篇 |
1978年 | 12171篇 |
1977年 | 10844篇 |
1976年 | 9416篇 |
1975年 | 10832篇 |
1974年 | 12458篇 |
1973年 | 12037篇 |
1972年 | 11534篇 |
1971年 | 10834篇 |
1970年 | 9924篇 |
1969年 | 9584篇 |
排序方式: 共有10000条查询结果,搜索用时 9 毫秒
131.
132.
Joseph Biederman Haitao Gao Ann K Rogers Thomas J Spencer 《Neuropsychopharmacology》2006,60(10):1106-1110
BACKGROUND: The validity of parent reports regarding children's attention-deficit/hyperactivity disorder (ADHD) symptoms has been questioned. This study assessed whether parent reports were as sensitive as teacher reports to document change in ADHD symptoms during clinical trials with atomoxetine. METHODS: Data were compared from two randomized, double-blind, placebo-controlled clinical trials of atomoxetine using different versions (parent or teacher) of the same rating scale (Attention-Deficit/Hyperactivity Disorder Rating Scale-IV [parent or teacher] Version: Investigator Administered and Scored - ADHD RS). Exclusion criteria included history of bipolar disorder, psychosis, seizures, alcohol abuse, or positive drug screen. Patients (6-16 years old) were treated with atomoxetine (titrated to a maximum dose of 1.8 mg/kg/day) administered once daily for up to 7 weeks. Parent and teacher ratings were compared using an analysis of covariance (ANCOVA) model. RESULTS: The analysis (n = 318) showed that treatment effects (mean change, baseline to endpoint) were similar between parent and teacher ratings (total, p = .762; inattention, p = .519; hyperactive/impulsive, p = .955). Effect sizes also were similar based on total scores (parent ratings = .69; teacher ratings = .63). CONCLUSIONS: Parent reports are as sensitive as teacher reports in assessing the efficacy of long-acting pharmacologic treatment for ADHD in children during clinical trials using the nonstimulant atomoxetine. 相似文献
133.
Lorusso F Kong D Jalil A. K. A A. AO 《世界核心医学期刊文摘》2006,2(6):25-26
目的:描述胚胎种植前遗传诊断在1例携带Ⅰ型白细胞黏附缺陷病(LAD-1)携带者并完成健康妊娠夫妇中的应用。设计:病例报道。机构:大学医院生殖中心。患者:1例男女双方都是LAD-1携带者的夫妇,女方CD18基因的外显子4携带有G400A置换,男方的外显子5携带有C562T置换。干预:标准体外受精(IVF)后第3天行卵裂期活检和分裂球遗传分析以检测2处突变以及21号染色体标记物。主要观察指标:1个未罹患LAD-1婴儿的出生。结果:得到15个卵母细胞,其中10个受精。8个胚胎适宜胚胎活组织检查。 相似文献
134.
Philip A. Rozario Nancy L. Morrow-Howell Enola K. Proctor 《Quality of life research》2006,15(4):755-759
Using the SF-12 to measure physical and mental functioning, the authors examine the intra-individual changes in health-related
quality of life (HRQOL) 6 months post-discharge for depressed older adults. In addition, they examine three sets of predictors
that might influence these changes. The sample of depressed older adults was recruited from an inpatient geropsychiatry unit.
Although their physical and mental health scores on the SF-12 were lower than comparable norms, the sample showed an average
increase in their mental functioning but a decrease in the physical functioning over the 6 months. Negative life-events were
significant predictors of people who reported no change in their mental health functioning and decreases in their physical
health functioning. Interestingly, those who experienced positive life events were more likely to report declines and younger
participants were more likely to report no change in their physical functioning. The findings indicate that the effects of
depression on HRQOL can have enduring effects on a sample of previously hospitalized older adults. The significance of life
event changes might signify the importance of taking into account non-traditional areas of medical interventions. Further,
the findings indicate the usefulness of the SF-12 quantifying HRQOL outcomes. 相似文献
135.
OLG München 《MedR Medizinrecht》2006,24(7):431-433
Abstrakt 1. Ein nicht ausgefülltes und nicht unterschriebenes Aufkl?rungsformular in der Krankenakte bildet ein Indiz nicht für, sondern
gegen die Durchführung eines Aufkl?rungsgespr?chs.
2. Wenn vor dem ?rztlichen Eingriff überhaupt keine Aufkl?rung erfolgt, genügt für den Beginn der Verj?hrung eines auf eine
Aufkl?rungspflichtverletzung gestützten Anspruchs die Kenntnis vom Eintritt schwerwiegender Komplikationen. Nicht erforderlich
ist das Wissen, dass sich ein typisches Risiko des Eingriffs verwirklicht hat. 相似文献
136.
137.
138.
Burkitt’s lymphoma is a high-grade, rapidly growing B-cell neoplasm. It is recognized by its aggressive course, brief median survival, and low rates of long-term survival. The authors discuss the case of a patient who acutely presented with intraabdominal complications from a new onset of Burkitt’s lymphoma. The clinical and pathological features, staging, treatment options, and survival data are reviewed. In addition, the role of surgical intervention is carefully analyzed. 相似文献
139.
La Creis R Kidd K Woodson P R Taylor D Albanes J Virtamo J A Tangrea 《European journal of cancer prevention》2003,12(4):317-320
Glutathione-S-transferase (GST) genes encode a family of detoxification enzymes that offer protection against endogenous and exogenous sources of reactive oxygen species (ROS). Germline variations in GST genes may alter the catalytic efficiency of GST isoenzymes leading to a potential increase in susceptibility to the genotoxic effects of ROS and electrophilic substances. A nested case-control study design was used to examine the association between the polymorphic GST genes and prostate cancer risk among Finnish male smokers of the ATBC Cancer Prevention Study. A case-case analysis was used to determine the association between these genetic polymorphisms and prostate cancer progression. Germline DNA was obtained from 206 prostate cancer cases and 194 controls frequency matched on age, intervention group and study clinic. Cases and controls were genotyped for three GST genes using MALDI-TOF mass spectrometry or multiplex polymerase chain reaction (PCR). Relative to the wild-type genotype, we observed a 36% reduction in prostate cancer risk associated with the GST-M1-null genotype (odds ratio (OR) 0.64, 95% confidence interval (CI) 0.43, 0.95). Unlike GST-M1, GST-T1-null (OR 0.74, 95% CI 0.42, 1.33) and GST-P1*B (OR 1.10, 95% CI 0.72, 1.69) were not strongly associated with prostate cancer risk. We did not observe any significant associations between the selected polymorphic GST genes and tumour grade or stage. In conclusion, we did not observe a direct association between polymorphic GST-T1 or GST-P1 and prostate cancer risk. Our observation of a relatively strong inverse association between the GST-M1-null genotype and prostate cancer risk needs to be confirmed in larger association studies. 相似文献
140.
Johannes Brettschneider Axel Petzold Sigurd D Süssmuth Georg B Landwehrmeyer Albert C Ludolph Jan Kassubek Hayrettin Tumani 《Movement disorders》2006,21(12):2224-2227
We aimed to evaluate the potential of the cerebrospinal fluid (CSF) axonal damage biomarker NfH(SMI35) in the laboratory-supported differential diagnosis of parkinsonian syndromes. Patients with idiopathic Parkinson's disease (PD; n = 22), multiple-system atrophy (MSA; n = 21), progressive supranuclear palsy (PSP; n = 21), corticobasal degeneration (CBD; n = 6), and age-matched controls (n = 45) were included. CSF levels of NfH(SMI35) were measured using ELISA. Levels of CSF NfH(SMI35) were elevated in PSP compared to PD and controls (P < 0.05 each). They were also significantly higher in MSA than in PD and controls (P < 0.05 each). NfH(SMI35) differentiated PD from PSP with a sensitivity of 76.5% and a specificity of 94.4%. Axonal damage as measured by CSF NfH(SMI35) is most prominent in the more rapidly progressive syndromes PSP and MSA as compared to PD or CBD. CSF NfH(SMI35) may therefore be of some value for the laboratory-supported differential diagnosis of atypical parkinsonian syndromes. 相似文献